secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001558370-24-000365
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences receives Nasdaq notice for missing annual meeting; reduces quorum
--------------------------------------------------------------------------------

- Nasdaq notified Jan 11, 2024 that company failed to hold annual meeting within 12 months of FYE 2022, violating Listing Rule 5620(a).
- Must submit compliance plan by Feb 26, 2024; if accepted, exception until June 28, 2024 to regain compliance.
- Company intends to hold meeting by Feb 26, 2024 and filed preliminary proxy on Jan 5, 2024.
- Board amended bylaws Jan 16, 2024 to reduce quorum from majority to one-third of voting power.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024000365/0001558370-24-000365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837024000365/rsls-20240111x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer